Calla Lily Clinical Care join Wellcome Leap’s antibiotics programme
Calla Lily Clinical Care, a women’s health-focused medical technology company, has joined Wellcome Leap’s Focused Antibiotics programme – a new $50m funded programme to transform how antibiotics are delivered and address the growing global threat of antimicrobial resistance (AMR). Founded by the Wellcome Trust in 2020, US non-profit Wellcome Leap… Read More